Strategic Acquisitions Propel Logiq Toward Biotech Expansion Logiq, Inc. is making significant moves with agreements to acquire both EVIMATE, an AI-driven medical device firm, and MedLab Essentials, a leader in cell and gene therapy. These deals, valued at $5 million and $100 million respectively, aim to diversify Logiq into healthcare technology and biotech, with plans for a major exchange uplisting.1